Pharmacogenomics (journal)

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Pharmacogenomics  
Cover
Discipline Pharmacogenomics
Language English
Edited by David Gurwitz, Howard McLeod, Munir Pirmohamed
Publication details
Publication history
2000–present
Publisher
Frequency 18/year
2.350
Standard abbreviations
Pharmacogenomics
Indexing
CODEN PARMFL
ISSN 1462-2416 (print)
1744-8042 (web)
OCLC no. 55059877
Links

Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.

Abstracting and indexing[edit]

The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]

References[edit]

  1. ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017. 

External links[edit]